H.R. 1316 · 115th Congress
Prescription Drug Price Transparency Act
- Stage
- In committee
- Sponsor
- Doug Collins
- Introduced
- 2017-03-02
- Latest action
- 2017-04-05 · Referred to the Subcommittee on Military Personnel.
Action history
- 2017-04-05Referred to the Subcommittee on Military Personnel.
- 2017-03-17Referred to the Subcommittee on Health.
- 2017-03-15Referred to the Subcommittee on Health.
- 2017-03-02Introduced in House
- 2017-03-02Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2017-03-02Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2017-03-02Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2017-03-02Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.